about
Redox control of senescence and age-related diseaseSenescence from G2 arrest, revisitedContact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence programFrom rapalogs to anti-aging formula.Gerosuppression in confluent cells.Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion.Cellular senescence and autophagy of myoepithelial cells are involved in the progression of in situ areas of carcinoma ex-pleomorphic adenoma to invasive carcinoma. An in vitro modelFasting levels of hepatic p-S6 are increased in old miceGeroconversion: irreversible step to cellular senescenceRejuvenating immunity: "anti-aging drug today" eight years later.Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).MicroRNA-15b regulates mitochondrial ROS production and the senescence-associated secretory phenotype through sirtuin 4/SIRT4Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.mTOR Inhibition: From Aging to Autism and Beyond.Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).ATF6α regulates morphological changes associated with senescence in human fibroblasts.Chemopreventative effects of tetrahydrocurcumin on human diseases.Cellular lifespan and senescence: a complex balance between multiple cellular pathways.Characterization of Senescence of Culture-expanded Human Adipose-derived Mesenchymal Stem CellsDNA damage regulates direct association of TOR kinase with the RNA polymerase II-transcribed HMO1 gene.While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts.
P2860
Q28074230-D211479C-3A32-4B6D-8ED3-E3286CD29DFBQ28088672-E271E4B3-EEBA-459E-B0A7-25989E0EC155Q28972583-6EE788C4-E5E5-43DD-AD81-F42027038BE8Q33829205-43F94E24-8DC8-4A25-A56A-B400FE642DA5Q34982499-152CCBBE-31B5-4A12-B260-23B2E8C40253Q35149607-319BA239-B7F3-40EB-8115-46ADF69D7C9FQ36087440-DE714486-36D5-4475-9705-A422A1AE6DB6Q36182265-0E382504-6434-4061-9BD8-9070B9562E07Q36186369-D7E71D1E-B455-4294-98C4-31767AB647FBQ36260537-5E71D84B-6DC0-4826-A9DF-FBF7E2FB0D2AQ36414149-41DDDC9E-6529-443A-99B8-569A47569C10Q36802020-A4CA7AA1-7CCE-4985-9153-225B545EB86DQ37351778-1A0FAFCE-2954-4416-BC9A-010C1883258CQ37385781-309FB426-FD9A-4318-B7EF-76E91DC1C71CQ37492314-3605EB8C-26DC-4F16-812E-C25749DA28A6Q37708694-14AE0C09-5165-453D-BB2E-41131564DEAEQ38162076-1A96A1F3-1AC7-480D-A6EF-63B94AC7041DQ38896922-1E414BE0-E064-4FC2-948F-15C6411503DEQ41907815-2E1A1092-9FEB-483F-847B-9861C5270C7BQ43491647-5EDFEA4A-AA3D-478C-8F38-D06C3B81FC13Q49713212-24C7606A-DD8A-41DB-8E4C-513673C04B22
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Senescence regulation by mTOR.
@en
type
label
Senescence regulation by mTOR.
@en
prefLabel
Senescence regulation by mTOR.
@en
P1476
Senescence regulation by mTOR
@en
P2093
Vjekoslav Dulic
P356
10.1007/978-1-62703-239-1_2
P407
P577
2013-01-01T00:00:00Z